Implantable Loop Recorders

Global Implantable Loop Recorders Market to Reach US$2.6 Billion by 2030

The global market for Implantable Loop Recorders estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. Manual Product, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Automatic Product segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$417.3 Million While China is Forecast to Grow at 14.2% CAGR

The Implantable Loop Recorders market in the U.S. is estimated at US$417.3 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$572.0 Million by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Implantable Loop Recorders Market – Key Trends & Drivers Summarized

What Is Driving the Clinical Relevance of Implantable Loop Recorders in Modern Cardiology?
Implantable loop recorders (ILRs), also known as insertable cardiac monitors (ICMs), have revolutionized long-term cardiac rhythm monitoring by enabling continuous ECG surveillance for up to three years. These subcutaneous devices are particularly valuable in diagnosing unexplained syncope, cryptogenic stroke, and intermittent arrhythmias, such as paroxysmal atrial fibrillation. Unlike traditional Holter monitors or external event recorders, ILRs eliminate the limitations of short-term data capture and patient non-compliance with wearable electrodes. This ability to provide uninterrupted cardiac monitoring, even in asymptomatic patients, significantly enhances diagnostic yield, especially in cases where arrhythmic episodes are infrequent or unpredictable.

Clinical guidelines from the American Heart Association (AHA) and European Society of Cardiology (ESC) increasingly recommend ILRs as first-line tools in patients with unexplained syncope or transient loss of consciousness, further legitimizing their place in cardiac diagnostic pathways. Beyond syncope, there is growing utilization of ILRs in post-stroke evaluation for cryptogenic causes, where undetected atrial fibrillation may be an underlying factor. These devices are also proving critical in long-term monitoring for patients with inherited arrhythmia syndromes or post-ablation monitoring for recurrence of atrial fibrillation, expanding their utility in both general cardiology and electrophysiology subspecialties.

How Are Technology Advancements Reshaping the Implantable Loop Recorder Landscape?
The past few years have witnessed rapid innovation in ILR design and data handling capabilities. New-generation devices are increasingly miniaturized, facilitating minimally invasive insertion procedures that can be performed in outpatient settings. For instance, some devices now measure less than 1 cubic centimeter in volume and can be implanted in under five minutes. These miniaturized form factors not only improve patient comfort but also reduce procedural risk and cost burden on healthcare systems. Battery longevity has also improved significantly, with most devices now lasting between three and four years without replacement.

On the digital front, integration with remote telemetry systems and smartphone-compatible patient apps has dramatically improved real-time data access and clinical workflow. Physicians can now receive instant alerts for critical events such as asystole, bradycardia, or atrial fibrillation episodes, enabling earlier interventions. In parallel, artificial intelligence and machine learning algorithms are being embedded into cloud-based platforms to reduce false positives and automate pattern recognition across large datasets. These capabilities are especially beneficial in remote patient monitoring programs, telecardiology services, and in managing chronic disease populations outside traditional clinical settings.

Which Clinical Applications Are Expanding?
North America and Europe currently lead global ILR adoption, driven by well-established reimbursement policies, strong clinical infrastructure, and early integration of remote monitoring technologies. However, emerging markets in Asia-Pacific and Latin America are witnessing a rise in implant volumes due to improved access to cardiac diagnostics, rising awareness of atrial fibrillation-related stroke, and increased investment in public cardiac health initiatives. Governments and insurers are also starting to recognize the cost-effectiveness of ILRs in reducing recurrent hospitalizations and stroke-related disability.

In terms of clinical use, while syncope diagnosis remains the leading indication, ILRs are seeing rapid uptake in secondary stroke prevention programs. Many stroke centers are incorporating ILRs into their diagnostic workup to detect occult paroxysmal atrial fibrillation—a common but underdiagnosed cause of embolic strokes. Furthermore, their role is expanding in electrophysiology for post-ablation surveillance and in structural heart disease management, particularly among patients with implanted cardiac devices like pacemakers or CRTs, where ILRs provide adjunctive diagnostic insights. Pediatric cardiology is another frontier, where ILRs are gaining interest for evaluating inherited rhythm disorders in younger populations, albeit with careful selection criteria due to anatomical and procedural considerations.

The Growth in the Implantable Loop Recorders Market Is Driven by Several Factors…
First, continuous innovation in device miniaturization and minimally invasive insertion techniques has significantly lowered the threshold for adoption across both high- and middle-income countries. This has opened new avenues for use in ambulatory and community-based cardiac care models. Second, the integration of remote monitoring technologies and cloud-based analytics platforms has turned ILRs into connected health tools, aligning well with the global shift toward digital health, decentralized care, and telemonitoring. These advancements allow cardiologists to efficiently manage larger patient cohorts while maintaining diagnostic precision.

Third, the expanding clinical use cases—particularly in cryptogenic stroke diagnostics, atrial fibrillation surveillance, post-ablation monitoring, and inherited rhythm disorder detection—are collectively enlarging the addressable patient pool. Additionally, supportive reimbursement policies in key markets such as the U.S., Germany, and Japan have been critical in driving both physician adoption and patient access. Fourth, rising global cardiovascular disease prevalence, especially atrial fibrillation and stroke, is fueling the need for early and reliable rhythm diagnostics, creating sustained demand for ILRs. Finally, market growth is also bolstered by the increasing availability of these devices in emerging regions, thanks to growing awareness, improving cardiology infrastructure, and targeted distribution strategies by leading device manufacturers.

SCOPE OF STUDY:

The report analyzes the Implantable Loop Recorders market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Manual Product, Automatic Product); Indication (Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication, Other Indications); End-User (Hospitals End-User, Cardiac Centers & Clinics End-User, Ambulatory Surgery Centers End-User)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Angel Medical Systems, Inc.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Insight, Inc.
• Cardiovascular Systems, Inc.
• ConMed Corporation
• Cook Medical
• GE Healthcare
• HeartWare International, Inc.
• Hill-Rom Holdings, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• LifeWatch Technologies
• Medtronic plc
• MicroPort Scientific Corporation
• Nihon Kohden Corporation
• Philips Healthcare
• Preventice Solutions
• ProgenyHealth

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.